Bolt Biotherapeutics, Inc.
BOLT
$4.28
$0.081.79%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 22.89M | 27.51M | 31.91M | 34.77M | 38.84M |
| Total Receivables | 15.00K | 973.00K | 948.00K | 100.00K | 710.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.65M | 1.41M | 1.96M | 2.68M | 2.18M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 200.00K | 375.00K | 784.00K | 784.00K | 784.00K |
| Total Current Assets | 25.75M | 30.26M | 35.61M | 38.34M | 42.51M |
|
|
|||||
| Total Current Assets | 25.75M | 30.26M | 35.61M | 38.34M | 42.51M |
| Net Property, Plant & Equipment | 19.61M | 20.48M | 21.38M | 22.24M | 23.21M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.65M | 1.68M | 1.16M | 1.20M | 1.03M |
| Total Assets | 48.03M | 56.75M | 65.05M | 75.50M | 85.86M |
|
|
|||||
| Total Accounts Payable | 1.74M | 1.44M | 1.52M | 1.85M | 1.53M |
| Total Accrued Expenses | 1.76M | 2.97M | 3.84M | 5.35M | 6.25M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.96M | 2.83M | 2.70M | 2.56M | 2.40M |
| Total Finance Division Other Current Liabilities | 896.00K | 1.19M | 1.91M | 2.55M | 3.38M |
| Total Other Current Liabilities | 896.00K | 1.19M | 1.91M | 2.55M | 3.38M |
| Total Current Liabilities | 7.34M | 8.44M | 9.97M | 12.31M | 13.56M |
|
|
|||||
| Total Current Liabilities | 7.34M | 8.44M | 9.97M | 12.31M | 13.56M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 19.35M | 20.13M | 20.89M | 21.62M | 22.31M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.51M | 1.68M | 2.10M | 2.72M | 3.18M |
| Total Liabilities | 28.21M | 30.24M | 32.95M | 36.66M | 39.05M |
|
|
|||||
| Common Stock & APIC | 487.86M | 487.31M | 486.26M | 485.85M | 485.21M |
| Retained Earnings | -468.02M | -460.78M | -454.15M | -447.00M | -438.44M |
| Treasury Stock & Other | -11.00K | -21.00K | -10.00K | -6.00K | 40.00K |
| Total Common Equity | 19.82M | 26.51M | 32.10M | 38.84M | 46.81M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 19.82M | 26.51M | 32.10M | 38.84M | 46.81M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 19.82M | 26.51M | 32.10M | 38.84M | 46.81M |
|
|
|||||